World's Best Scientists 2026 revealed!
Evangelos Andreakos

Evangelos Andreakos

D-Index & Metrics

Immunology

D-Index
58
Citations
12033
World Ranking
3523
National Ranking
6

Evangelos Andreakos publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Evangelos Andreakos sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 154 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Evangelos Andreakos D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Evangelos Andreakos sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Evangelos Andreakos is affiliated with the Academy of Athens in Greece and has a research focus primarily within medicine and immunology and microbiology. Their work spans several subfields including immunology, infectious diseases, molecular biology, epidemiology, and pulmonary and respiratory medicine.

The scientist has contributed extensively to the study of COVID-19 and related immune responses. Their research topics include:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • Interferon and immune responses
  • Inflammasome and immune disorders
  • Immune Cell Function and Interaction
  • Atherosclerosis and Cardiovascular Diseases

Evangelos Andreakos has published papers in a variety of scientific journals. Notable publications include:

  • "Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison," 2020, Nature Immunology
  • "Human genetic and immunological determinants of critical COVID-19 pneumonia," 2022, Nature
  • "Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis," 2022, Trends in Molecular Medicine
  • "Studying severe long COVID to understand post-infectious disorders beyond COVID-19," 2022, Nature Medicine
  • "COVID -19: lambda interferon against viral load and hyperinflammation," 2020, EMBO Molecular Medicine

Frequent publication venues for their work include:

  • The Journal of Experimental Medicine
  • Allergy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Immunology
  • Nature

Evangelos Andreakos collaborates regularly with several researchers. Frequent co-authors include:

  • Petter Brodin
  • Jacques Fellay
  • Rabih Halwani
  • Jean-Laurent Casanova
  • YL Lau

Best Publications

  • The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

    A. M. Malfait;R. Gallily;P. F. Sumariwalla;A. S. Malik

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis.

    Claudia Monaco;Evangelos Andreakos;Serafim Kiriakidis;Claudia Mauri

  • Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.

    Ioanna E. Galani;Vasiliki Triantafyllia;Evridiki Evangelia Eleminiadou;Ourania Koltsida

  • Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.

    Ioanna Evdokia Galani;Nikoletta Rovina;Vicky Lampropoulou;Vasiliki Triantafyllia

  • Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

    Unknown

  • VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2

    Serafim Kiriakidis;Evangelos Andreakos;Claudia Monaco;Brian Foxwell

  • Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP

    Evangelos Andreakos;Sandra M. Sacre;Clive Smith;Anna Lundberg

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • Cytokines and anti-cytokine biologicals in autoimmunity: present and future

    Evangelos T Andreakos;Brian M. J. Foxwell;Fionula M Brennan;Ravinder N Maini

  • The many facets of macrophages in rheumatoid arthritis

    Eleni Siouti;Evangelos Andreakos;Evangelos Andreakos

  • The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis.

    Sandra M. Sacre;Evangelos Andreakos;Serafim Kiriakidis;Parisa Amjadi

  • Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?

    Evangelos Andreakos;Brian Foxwell;Marc Feldmann

  • IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease

    Ourania Koltsida;Michael Hausding;Athanasios Stavropoulos;Sonja Koch

  • Neutrophils in viral infections: Current concepts and caveats.

    Ioanna E. Galani;Evangelos Andreakos

  • T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases.

    Claudia Monaco;Evangelos Andreakos;Serafim Kiriakidis;Marc Feldmann

  • Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.

    Christos I Maratheftis;Evangelos Andreakos;Haralampos M Moutsopoulos;Michael Voulgarelis

  • Autoantibodies against type I IFNs in patients with critical influenza pneumonia

    Unknown

  • COVID-19: lambda interferon against viral load and hyperinflammation.

    Evangelos Andreakos;Evangelos Andreakos;Sotirios Tsiodras

  • SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

    Vanessa Sancho-Shimizu;Petter Brodin;Aurélie Cobat;Aurélie Cobat;Aurélie Cobat;Catherine M Biggs

  • Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.

    Evangelos Andreakos;Clive Smith;Serafim Kiriakidis;Claudia Monaco

  • Toll-like Receptor 7–triggered Immune Response in the Lung Mediates Acute and Long-Lasting Suppression of Experimental Asthma

    Charoula Xirakia;Ourania Koltsida;Athanasios Stavropoulos;Artemis Thanassopoulou

  • Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation

    Maria Salagianni;Ioanna E. Galani;Anna M. Lundberg;Constantinos H. Davos

Frequent Co-Authors

Marc Feldmann
Marc Feldmann University of Oxford
Brian M. J. Foxwell
Brian M. J. Foxwell Imperial College London
Nikolaos G. Papadopoulos
Nikolaos G. Papadopoulos National and Kapodistrian University of Athens
Ewa M. Paleolog
Ewa M. Paleolog University of Oxford
Paschalis Sideras
Paschalis Sideras Academy of Athens
Laurent Abel
Laurent Abel Université Paris Cité
Fionula M. Brennan
Fionula M. Brennan University of Oxford
Aurora Pujol
Aurora Pujol Institut d'Investigació Biomédica de Bellvitge
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Giuseppe Novelli
Giuseppe Novelli University of Rome Tor Vergata

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open additional career options. Many students consider nursing paths that complement immunological knowledge, such as becoming a Licensed Practical Nurse (LPN). There are several accredited LPN programs easy to get into, providing a practical entry point to healthcare with flexible online options.

Advancing further, nurse practitioners play a vital role in patient care with specialized expertise. If you’re seeking an accessible option, it's useful to identify which nurse practitioner program is easiest to enroll in, balancing workload and credentials.

For those interested in mental health, combining immunology insights with psychiatric nursing is a growing field. The top psychiatric mental health nurse practitioner programs online offer excellent clinical placements to gain real-world experience while studying remotely.

Cost is a major factor for many students, and finding affordable education options is crucial. You can explore some of the cheapest psychiatric nurse practitioner programs available online to minimize expenses without sacrificing quality.

Best Scientists Citing Evangelos Andreakos

Trending Scientists

Recently Published Articles